A stunning result for HCQ +Az treatment for COVID-19 patients in Qatar! A Limerick.

The HCQ test made in Qatar

is stunning, that is all I can utter

For the death rate is low

A great fearmonger blow

Ignore it! The media mutter.

Qatar is an interesting country. It hosts America’s biggest Air base in the Middle East. With a population of only 2,8 million people it has 45,465 people that tested positive for the coronavirus, or 1.58% of the population, the highest in the world reported so far, bur only 26 deaths so far, only 0.009%, and there are nearly 400 recoveries for every death, the highest in the world.

How can that be? Does Qatar have a very unusual population profile? Yes, indeed

but it is not because of many children, no, over half of the population is working age males, nearly all guest workers. This explains a lot, but even that is not the main cause.

No, they have done a nearly universal medical protocol for all that test positive for the COVID-19 virus. All will get Hydroxychloroquine + Azithromycin , but a random sample will be selected for a small, double blind study. It started April 14 and ended May 14. The results will be published May 30 of so, but we don’t have to wait for the results of that test to verify the effectiveness of this medical treatment if begun as soon as symptoms materialize. To have the highest infection rate and the lowest death rate in the world is sufficient reason for me to advocate HCQ + AC for all eligible testing positive. Maybe if you include Zinc in the protocol the results would be even better, but we cannot wait for all the results to come in. Let us save lives now!

Appendix: Some were not be eligible for this study. The exclusion criteria were:

Ages Eligible for Study:	18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patient is in HMC facility for low-acuity, Covid-positive patients being quarantined.
Positive Covid test on qualitative assay used during routine care (i.e. not as part of Q-PROTECT (that is: victims given the placebo to make it a true random test)
Age at least 18

Exclusion Criteria:

Treating physician judges patient not appropriate for study participation for any reason
Age <18
Breastfeeding or pregnancy (patient-reported pregnancy status is sufficient)
Hypersensitivity to chloroquine or HC or AZ
History of or known QT prolongation
- EKG required before study entry and on each visit during the subject’s first seven days on pro-tocol, during the time period HC is being taken
- Baseline QTc >480 if QRS width normal; QTc >510 if QRS >120
Known G6PD deficiency, porphyria, or retinopathy (eye exam prior to study entry)
Known hepatic or renal disease (or abnormality on liver or renal function testing at study day 1)
Low magnesium or low potassium (by testing on day 1)
Current (pre-study) therapy with antimalarial or dapsone
Current (pre-study) therapy with antiviral agents (e.g. oseltamivir)
Tisdale36 score exceeding 6 as tallied below (based on ACC recommendations)*
- 1 point each: age>67, female sex, or being on loop diuretic
- 2 points each: serum potassium <3.6, QTc>449, acute myocardial infarction
- 3 points each: sepsis, heart failure, QT-prolonging drugs

Hydroxychloroquine + Zinc is the answer? Check the death rates of nine countries that use it.

This is a very interesting chart:

But wait. Not so fast. These countries have a younger population, and the death rate is much lower for younger people. This chart tells it all.

The death rate doubles for every 8 years as you age or about 9% per year. The world median age is 30.4 years. So let the world death rate be the norm

World death rate as of May 21 is 6.42% of diagnosed cases.

Turkey: Death rate 2.77%, median age 30.9, adjusted death rate 2.64%

South Korea: Death rate 2.37%, median age 30.9, adjusted death rate 2.26%

Malaysia: Death rate 1.61%, median age 28.5, adjusted death rate 1.91%

Senegal: Death rate 1.13%, median age 18.8, adjusted death rate 3.00%

Costa Rica: Death rate 1.11%, median age 31.3, adjusted death rate 1.02%

United Arab emirates: Death rate 0.88%, median age 30.9, adjusted death rate 0.84%

Bahrain: Death rate 1.43%, median age 32.3, adjusted death rate 1.20%

Morocco: Death rate 2.70%, median age 29.3, adjusted death rate 2.92%

Russia: Death rate 1.00%, median age 30.9, adjusted death rate 0.95%

Taking the average, not adjusted for the size of the populations we get the average adjusted death rate for countries, where people are taking HCQ + Zinc when diagnosed positive, is 1.89%.

This means that the risk of death is reduced by a factor of 3.4 if HZQ + Zinc is taken as early as possible after a positive diagnosis for coronavirus!

These 9 countries are living proof of it. Why are we not implementing it today?

President Trump is taking hydroxychloroquine! The international results are overwhelming, he is right!

In 2005 Dr. Anthony Fauci,the director of the (NIAID) National Institute of Allergy and Infectious Diseases, a position he still holds received the encouraging news that Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. The SARS epidemic petered out, ao the clinical trial was never executed.

Now the news about the efficacy of HydroxyChloroquine is coming in hot and heavy. The results are very encouraging. This is from a recent study in Marseilles, France:

We retrospectively report on 1061 SARS-CoV-2 positive tested patients treated for at least three days with the following regimen: HCQ (200 mg three times daily for ten days) + AZ (500 mg on day 1 followed by 250 mg daily for the next four days). Outcomes were death, clinical worsening (transfer to ICU, and >10 day hospitalization) and viral shedding persistence (>10 days).

Results

A total of 1061 patients were included in this analysis (46.4% male, mean age 43.6 years – range 14–95 years). Good clinical outcome and virological cure were obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage was observed in 47 patients (4.4%) and was associated to a higher viral load at diagnosis (p < .001) but viral culture was negative at day 10. All but one, were PCR-cleared at day 15. A poor clinical outcome (PClinO) was observed for 46 patients (4.3%) and 8 died (0.75%) (74–95 years old). All deaths resulted from respiratory failure and not from cardiac toxicity. Five patients are still hospitalized (98.7% of patients cured so far). PClinO was associated with older age (OR 1.11), severity of illness at admission (OR 10.05) and low HCQ serum concentration. PClinO was independently associated with the use of selective beta-blocking agents and angiotensin II receptor blockers (p < .05). A total of 2.3% of patients reported mild adverse events (gastrointestinal or skin symptoms, headache, insomnia and transient blurred vision).

Conclusion

Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with a very low fatality rate in patients.

Since then, prescriptions for the drug cocktail in Marseilles is up 7000%, and is also increasing in the rest of France, especially the Paris region.

But France is by no means the first country to go all out prescribing the drug cocktail. At least twelve countries are doing it, and Turkey and Morocco prescribe it to all with COVID-19 symptoms ( after first checking their heart). Russia joined six weeks later. Here are the results:

If we look at the results from onset to today, some interesting facts stand out

Turkey: Death rate 50 per million. ratio of recovered cases/death is 37

Morocco: Death rate 5 per million. ratio of recovered cases/death is 19.6

Russia: Death rate 19 per million. ratio of recovered cases/death is 19.6 and rising, but they started six weeks later and have not yet reached their infection maximum.

France: Death rate 433 per million. ratio of recovered cases/death is 2.2, but their new case maximum was 11 weeks ago and the maximum death rate was 9 weeks ago, way before any prescriptions increased.

U.S. does not do an even job of reporting recovered cases, so the results will only be valid for some states. Michigan seems to be one state that records recoveries.

Michigan: Death rate 492 per million. ratio of recovered cases/death is 5.7

The best state is South Dakota, but there Governor Kristi Noem conducted a semi clinical (not double blind) trial, and the results speak for themselves.

South Dakota: Death rate 50 per million. ratio of recovered cases/death is 63.27 !!

My suggestion is this: Give the HCQ+ AZT + Zinc +Vitamin D for 5 days as soon as symptoms occur. Give HZQ + Zinc + Vitamin D for 5 days to all the infected person’s contacts, then their quarantine is over, otherwise it is 14 days. Check for heart rhythm problems, but otherwise go ahead.

The results from Turkey + Russia + Morocco involved more than 170,000 recovered cases, far more than any clinical study, and showed the effect both before and after HCQ became the drug of choice, so the effect is real enough!

Sweden is leading the way. Throw out the Chinese infiltrators!

Sweden is a globalist country. Ever since Dag Hammarskjöld was Secretary of the U.N. Sweden has advocated leadership in foreign aid and is leading the world in foreign aid as a percentage of GNP (1.45% in 2015). They welcome immigrants and refugees, the foreign born population is now over 20%. When the coronavirus outbreak started in Wuhan, China, Sweden pitched in and sent over 100,000 masks to help out.

All of this changed when the Chinese quarantined over 50 million people in and around Wuhan, prevented all travel within China to and from the guaranteed provinces but allowed international travel to continue in and out of Wuhan International Airport, thereby spreading the Wuhan virus worldwide, but stopping it within China. When the virus hit Sweden they tried to replenish their protection equipment they found out that China had mopped up nearly all supplies from the whole world and was now reselling them at scalpers’ prices, if they were available at all.

This did not sit well with the Swedes, they have now abolished all sister city arrangements with China, the last to go was the Gothenburg – Shanghai arrangement. Gone are also the Confucius institutes, and finally the last Confucius classroom in the little town of Falkenberg.

We should do the same thing. San Francisco has a sister city arrangement with Shanghai, Pittsburgh has one with Wuhan, and so on. Suspend them all! Likewise abolish all Confucius Institutes, and they are legion

Besides providing Chinese propaganda they are a major source of “information gathering.” The Chinese people are wonderful, but before they are sent off to the U.S. to study they must swear loyalty to the Communist Government, and so the Confucius Institutes are in reality low level spy operations.

Was Sweden right? Social distancing is better than stay at home and lockdown of the economy

Sweden and New Jersey are about the same size population wise, Sweden has 10 million people, New Jersey has about 9.2 million. For both, the foreign born population is about 20 percent. When the coronavirus pandemic hit they took quite different action at the same time:

New Jersey went into full lockdown with a near complete halt to the economy.

Sweden issued social distancing, crowds and travel restrictions, and hygiene regulations, but kept businesses and restaurants open within limits.

Yer their death rates followed the same bell curve as the disease marched on

Yet, there was one big difference, the deaths from the corona virus was three times larger in New Jersey than in Sweden, the total cases was five times larger.

It is always touted that we need more testing, New Jersey has made 451,696 tests, Sweden only 177,500. More testing will find more mild and asymptomatic cases, but the deaths will be the same.

The solution is to let the young and healthy develop herd immunity, but protect the vulnerable, such as the old, obese, diabetic, people with hypertension, weak hearts or a compromised immune system.

Coronavirus death rates and trends for the five worst states versus the five best states. Look at Michigan versus South Dakota.

The trend of the five worst and the five best states of Covid-19 death rates versus percent of population tested:

State death rate trend percentage of population tested

. May 8 May 11 up/down May 8 May 11

Michigan 9.48% 9.64% up 2.4% 3.1%

2. Connecticut 8,87% 8.91% up 3.1% 3.7%

3. New York 7.80% 7.80% __ 5.6% 6.2%

4. Lousiana 7.23% 7.32% up 4.4% 4.9%

5. New Jersey 6.55% 6.71% up 4.4% 4.9%

….

46. Tennessee 1.66% 1.61% down 3.4% 4.0%

47. Nebraska 1.17% 1.16% down 2.0% 2.5%

48. Wyoming 1.08% 1.05% down 2.1% 2.3%

49. Utah 1.03% 1.06% up 4.3% 4.7%

50. South Dakota 0.98% 0.94% down 2.4% 2.7%

Beside from the obvious fact that the five worst states are all run by Democrat Governors and the five best state are all run by Republicans, these are my observations:

The five worst states show a rising death rate, even though the test rate is increasing. The five best state show a falling death rate, which is to be expected as testing is increased.

Michigan has a Detroit problem. The COVID-19 death rate there is over 10%, many got turned away from the few hospitals and were sent home without first being tested. Governor Gretchen Whitmer seems more interested in controlling the healthy population than to protect the vulnerable.

Why Connecticut is second on the list I don’t know, but Hartford County has a problem with a death rate over 10%. It is also next to New York, where the death rate in New York City still is either 7.92% or 10.7% if you include probable deaths.

The problem with New York is that Governor Cuomo ordered nursing home facilities to accept COVID-19 patients, they are not set up to handle highly contagious patients, and so the infection and death rate among the most vulnerable population skyrocketed. One interesting statistics is that two thirds of all New York COVID-19 cases were from people staying home, not going out at all.

The problem with Louisiana is that it let Mardi Gras proceed, people came, did their thing and went back to where they came from, often to under-served areas.

New Jersey is next to New York. Need I say more?

On the other hand, the five best states concentrated their efforts to protect the at risk people, concentrating on hygiene and social distancing rather than trying to micromanage the healthy population. There seems to be no improvement in the outcome by adding testing. In addition the death rate among the five worst states is still rising, whereas the death rate in the five best states is declining.

Governor Kristi Noem of South Dakota, the state with the best outcome of all states so far did order a clinical test of using the combination Hydroxychloroquine + Azithromycin + Zinc for five days and that may be the reason the death rate is less than 1 percent. Unfortunately the FDA is concerned that hydroxychloroquine and chloroquine are being used inappropriately to treat non-hospitalized patients for coronavirus disease (COVID-19) or to prevent that disease. Quote:” We authorized their temporary use only in hospitalized patients with COVID-19 when clinical trials are not available, or participation is not feasible, through an Emergency Use Authorization (EUA). These medicines have a number of side effects, including serious heart rhythm problems that can be life-threatening.”

Here is my suggestion: Issue an executive order opening up a clinical study in the effectiveness of COVID-19 treatment with Hydroxychloroquine + Azithromycin + Zinc for five days, and open it up to any qualified Physician or Nurse Practitioner who want to participate. They do the heart test, check for other ailments and report the results to a central data base and a follow up report, and even if it is not a double blind study, once you have a million or so results the FDA can approve the medication. In the meantime over 90% of the patients were getting better, and hopefully nobody had given it to patients with severe preexisting heart conditions. The risk is minimal. It is already approved for Lupus, Rheumatism and Malaria, and the same protocol should apply here.

It is very important the drugs are administered as early as possible. By the time the patient is admitted to a hospital it may be too late. Especially if the patient is already on a ventilator it may do more harm than good.

Why is this study even necessary? This medication is too cheap, it is generic, so no pharmaceutical company is willing to foot the bill on something unprofitable, so it must be done by a university or through a government agency.

It is not that daring a thing to do. Here is a result of a COVID-19 study with more than 6,200 physicians in 30 countries.

The three most commonly prescribed treatments among COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
Hydroxychloroquine usage among COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
Hydroxychloroquine was overall chosen as the most effective therapy among COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters)
- 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K.
The two most common treatment regimens for Hydroxychloroquine were:
- (38%) 400mg twice daily on day one; 400 mg daily for five days
- (26%) 400mg twice daily on day one; 200mg twice daily for four days
Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients
Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients.

And this is a very recent tweet from president Donald Trump, without which frequent and persistent recommendation this drug combination would have already been approved, as it is in at least 12 other countries.

Make a nationwide clinical test of using the combination Hydroxychloroquine + Azithromycin + Zinc for five days to treat COVID-19 patients. It will save lives!

The five worst and the five best states of Covid-19 death rates versus percent of population tested:

Michigan 9.48% death rate and 2.4% of population tested

2. Connecticut 8,87% 3.1%

3. New York 7.80% 5.6%

4. Lousiana 7.23% 4.4%

5. New Jersey 6.55% 4.4%

….

46. Tennessee 1.66% 3.4%

47. Nebraska 1.17% 2.0%

48. Wyoming 1.08% 2.1%

49. Utah 1.03% 4.3%

50. South Dakota 0.98% 2.4%

Beside from the obvious fact that the five worst states are all run by Democrat Governors and the five best state are all run by Republicans, these are my observations:

Why Connecticut is second on the list I don’t know, but Hartford County has a problem with a death rate over 10%

The problem with Louisiana is that it let Mardi Gras proceed and people came, did their thing and went back to where they came from, often to under-served areas.

New Jersey is next to New York. Need I say more?

On the other hand, the five best states concentrated their efforts to protect the at risk people, concentrating on hygiene and social distancing rather than trying to micromanage the healthy population. There seem to be no improvement in the outcome by adding testing. In addition the death rate among the five worst states is still rising, whereas the death rate in the five best states is declining.

Governor Kristi Noem of South Dakota, the state with the best outcome so far did order a clinical test of using the combination Hydroxychloroquine + Azithromycin + Zinc for five days and that may be the reason the death rate is less than 1 percent. Unfortunately the FDA is concerned that hydroxychloroquine and chloroquine are being used inappropriately to treat non-hospitalized patients for coronavirus disease (COVID-19) or to prevent that disease. Quote:” We authorized their temporary use only in hospitalized patients with COVID-19 when clinical trials are not available, or participation is not feasible, through an Emergency Use Authorization (EUA). These medicines have a number of side effects, including serious heart rhythm problems that can be life-threatening.”

It is very important the drug is administered as early as possible. By the time the patient is admitted to a hospital it may be too late. Especially if the patient is already on a ventilator it may do more harm than good.

It is not that daring a thing to do. Here is a result of a COVID-19 study with more than 6,200 physicians in 30 countries.

The three most commonly prescribed treatments among COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
Hydroxychloroquine usage among COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
Hydroxychloroquine was overall chosen as the most effective therapy among COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters)
- 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K.
The two most common treatment regimens for Hydroxychloroquine were:
- (38%) 400mg twice daily on day one; 400 mg daily for five days
- (26%) 400mg twice daily on day one; 200mg twice daily for four days
Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients
Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients.

Sweden was right after all. No lock-down but hygiene, social separation and limited gatherings will work just as well.

As Europe and North America continue suffering their steady economic and social decline as a direct result of imposing “lockdown” on their populations, other countries have taken a different approach to dealing with the coronavirus threat. You wouldn’t know it by listening to western politicians or mainstream media stenographers, there are also non-lockdown countries. They are led by Sweden, Iceland, Belarus, Japan, South Korea and Taiwan. Surprisingly to some, their results have been as good or better than the lockdown countries, but without having to endure the socio-economic chaos we are now witnessing across the world. For this reason alone, Sweden and others like them, have already won the policy debate, as well as the scientific one too.

Unlike many others, Sweden has not enforced any strict mass quarantine measures to contain COVID-19, nor has it closed any of its borders. Rather, Swedish health authorities have issued a series of guidelines for social distancing and other common sense measures covering areas like hygiene, travel, public gatherings, and protecting the elderly and immune compromised. They have kept all preschools, primary and secondary schools open, while closing college and universities who are now doing their work and lectures online. Likewise, many bars and restaurants have remained open, and shoppers do not have to perform the bizarre ritual of queuing around the block standing 2 meters apart in order to buy groceries.

According to the country’s top scientists, they are now well underway to achieving natural herd immunity. It seems this particular Nordic model has already won the debate.

Because Sweden decided to follow real epidemiological science and pursue a common sense strategy of herd immunity, it doesn’t need to “flatten of the curve” because its strategic approach has the added benefit of achieving a much more gradual and wider spread.

This chart proves the point:

How well are the other non-lockdown countries doing?

Iceland has a total case count of 1799 and a death count of 10, all between March 21 and April 20.

Belarus has a total case count of 16705 and a death count of 99, and the death chart looks like this:

Here the daily death count has not risen above 5 per day. in a country of 9.5 million

Japan has a total case count of 14571 and a death count of 474, and the death chart looks like this:

Japan shows a unique pattern: It looked that they had beaten the coronavirus early, but then in April it started up again, but always at manageable levels.

South Korea has a total case count of 10793 and a death count of 250, and the death chart looks like this:

The death count rises, then stays constant for about 2 months and then declines, but slower than the new case count.

Taiwan has a total case count of 432 and a death count of 6, all between March 20 and April 10. And this in a country of 24 million!

Compare this with Belgium, the center of European Union, and roughly the size of Sweden, it has a total case count of 49906 and a death count of 7844, and the death chart looks like this

This chart, representative of a lock-down country shows the same rise, flattop and decline as the charts of the non lock-down countries, but has a much higher death rate.

Quotes from https://www.zerohedge.com/health/why-sweden-has-already-won-debate-covid-19-lockdown-policy

this blog has been updated with values up to July 9: https://lenbilen.com/2020/07/10/sweden-was-right-no-lock-down-but-hygiene-social-separation-and-limited-gatherings-will-work-just-as-well/

HZQ-AZ-Z 5 day cheap cure to early COVID-19 onset is over 90% effective. Why not approve it now?

Remdesivir Just Became The First Drug to Show a ‘Clear-Cut’ Effect in Treating COVID-19

ISSAM AHMED, AFP

30 APRIL 2020

COVID-19 patients on the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as a top US scientist hailed the drug’s “clear-cut” benefit.

This was touted as a major breakthrough by Dr Fauci in a Presidential briefing yesterday, and indeed, it seems to show efficacy. Patients on the drug, made by Gilead Sciences, had a 31 percent faster time to recovery than those on a placebo. “Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo,” it said. The results also suggested that people who were on the drug were less likely to die, although the difference was quite small. The mortality rate was 8.0 percent for the group receiving remdesivir versus 11.6 percent for the placebo group.

On the other hand the FDA issued a warning for using the drug-combination HydroxyChloroQuine + AZithromycin + Zinc. AZ was approved in 1988, HCQ has been approved for malaria in over 50 years, and for Lupus and Rheumatism for decades, and all that requires for prolonged use is that an EKG is taken periodically to check for possible heart arrhythmia. It is an easy 5 day application and it shows good outcome in 91.7% of 1061 patients. Poor outcome was observed by 4,7% and in 0,47% the patient died. The age of those who died was 74 – 95 years old. If they had not taken this medication the death rate for people of that age is 5 – 8%. This is taken from the famous Marseille study.

Sequential CQ / HCQ Research Papers and Reports

January to April 20, 2020

Executive Summary Interpretation of the Data In This Report

The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagious infectivity in most cases.

A cohort of 1061 COVID-19 patients, treated for at least 3 days with the HCQ-AZ combination and a follow-up of at least 9 days was investigated. Endpoints were death, worsening and viral shedding persistence. From March 3rd to April 9th, 2020, 59,655 specimens from 38,617 patients were tested for COVID-19 by PCR. Of the 3,165 positive patients placed in the care of our institute, 1061 previously unpublished patients met the inclusion criteria for a Hydroxychloroquine –Azithromycin trial.

Mean age was 43.6 years old and 492 were male (46.4%), As in other studies, no cardiac toxicity was observed in this study.

A good clinical outcome and virological cure was obtained in 973 patients out of a total pf 1061 patients within 10 days (91.7%).

Mortality was significantly lower in patients who had received > 3 days of HCQ-AZ than in patients treated with other regimens both at IHU and in all Marseille public hospitals

A poor outcome was observed for 46 patients (4.3%); –10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old), 31 required 10 days of hospitalization or more.

Among this group, 25 patients are now cured and 16 are still hospitalized (98% of patients cured so far).

Why the different approaches to these two medications?

Most of the rest of the world are jumping on the HCQ-AZ-Z opportunity. Why not US?

Vitamin D – one weapon to combat the coronavirus.

The organization Grassroots health put out the results of 212 people that had the COVID-19 virus, roughly 50 each having a critical or severe or normal or mild outcome. The results were stunning. Nearly all with a high level of vitamin D level in the blood had a mild outcome, as opposed to those with a vitamin D deficiency.

Up to now vitamin D deficiency has mostly been a concern for the people with the following risk factors, but not as a virus fighter.

Osteoporosis or other bone disorder
Previous gastric bypass surgery
Age; vitamin D deficiency is more common in older adults.
Obesity
Lack of exposure to sunlight
Having a darker complexion
Difficulty absorbing fat in your diet

It should be fairly simple and fast to expand this analysis to a larger sample of people that also include people with antibodies to COVID-19 but never showed any symptoms.

If this holds true, we did the exact wrong thing by keeping people indoors in hope to slow the spread. Instead we should have encouraged people to be outdoors as much as possible, still practicing hygiene and social distance, give vitamin D to all over 65 (4000 IU), to all obese and people of dark complexion.

This is by no means the only suggestion, but it is one more weapon in the arsenal to combat this virus.